GVOKE Trademark

Trademark Overview

On Friday, June 22, 2018, a trademark application was filed for GVOKE with the United States Patent and Trademark Office. The USPTO has given the GVOKE trademark a serial number of 88011935. The federal status of this trademark filing is REGISTERED as of Tuesday, March 24, 2020. This trademark is owned by Xeris Pharmaceuticals, Inc.. The GVOKE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
gvoke

General Information

Serial Number88011935
Word MarkGVOKE
Filing DateFriday, June 22, 2018
Status700 - REGISTERED
Status DateTuesday, March 24, 2020
Registration Number6019623
Registration DateTuesday, March 24, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 29, 2018
Primary Code005
First Use Anywhere DateMonday, November 4, 2019
First Use In Commerce DateMonday, November 4, 2019

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Trademark Events

Event DateEvent Description
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 22, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 22, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 24, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, February 20, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 19, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 2, 2020NON-FINAL ACTION E-MAILED
Thursday, January 2, 2020SU - NON-FINAL ACTION - WRITTEN
Monday, December 9, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, December 2, 2019USE AMENDMENT FILED
Monday, December 9, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 2, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, June 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2019SOU EXTENSION 1 GRANTED
Friday, June 21, 2019SOU EXTENSION 1 FILED
Friday, June 21, 2019TEAS EXTENSION RECEIVED
Tuesday, January 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 11, 2018ASSIGNED TO EXAMINER
Friday, June 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 26, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

gvoke metabolic pharmaceutical diabetes diseases treatment products syringes filled vials containing